Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a drink speed up muscle recovery? new study puts liquid IV to the test

NCT ID NCT07224867

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study will test whether a multi-ingredient recovery supplement from Liquid IV helps muscles recover faster after exercise. Thirty healthy, active adults will take either the supplement or a placebo after workouts, and researchers will measure strength, power, soreness, and hydration. The goal is to see if the supplement reduces muscle damage and speeds up recovery for people who exercise regularly.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
proprietary post-workout recovery supplement (dietary supplement)
What this could lead to
If it works, this could provide a convenient supplement to help active people recover faster from exercise with less soreness.
What could go wrong
This is a small, early-stage study with only 30 participants, and the supplement may not show significant benefits over a placebo. Results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy males or females aged 18-55 years old. * Must be recreationally trained or trained/developmental as previously defined (McKay et al., 2021). * Able to read and write in English. * Cessation of current use of tart cherry extract, protein powders, essential amino acids/BCAAs, calcium fructoborate, boron, or anabolic agents for a minimum of 1 week prior to, and throughout the duration of the study. * Willing to maintain regular supplement routine otherwise during the trial, and will not introduce or discontinue a supplement, other than what was previously mentioned. * Will not participate in any strenuous exercise for a minimum of 1-week prior to exercise performance assessments, as well as during the days of exercise testing. Strenuous exercise as defined for this study includes ½ and full marathons (or more), heavy (i.e.,\>80% 1RM) lifting, and any high intensity, physical activity that could make your muscles sore. * During the study, you agree not to take any NSAIDs or other anti-inflammatory medications. Exclusion Criteria: * Sedentary * Highly trained/national level or professional athlete * Known diagnosis of any cardiovascular, metabolic, musculoskeletal, endocrine, or renal disease/disorder. * Recent musculoskeletal injury (\<3-months) * Recent orthopedic surgery (\<12-months) * History or current malignancy. * Current respiratory infection (i.e., cold) or high temperature (fever) within the past 4-weeks. * Previous gastrointestinal surgery within the past 12 months. * Regular smoker. * Regular drinker (\>14 drinks per week). * Those regularly using anti-inflammatory drugs within the last 4-weeks. * Current use of prescription medications that may influence adaptation to exercise (hormone therapies, peptides, etc.). * Allergies to study-related materials. * Any condition that impairs their ability to complete the required exercises. * Female subjects must not be pregnant or lactating. * Are unable to provide informed consent or are non-English speakers. * Presently using GLP-1 medications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Muscle damage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Applied Science & Performance Institute

    Tampa, Florida, 33634, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.